This review summarizes the mechanisms of action and clinical activity of IMiDs in MM. Multiple myeloma (MM) is a malignant plasma cell disorder accounting for approximately 10% of all hematologic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback